Introduction: Remifentanil and propofol infusion using TCI pumps has proven to be beneficial for the practice of anesthesia but the availability of these systems is limited. Objective: Designing a pharmacokinetic model-based algorithm for calculating manual infusion regimens to achieve plasma and effect-site concentrations that may be used in volume infusion pumps, and to compare the difference between the desired and the forecasted concentrations via pharmacokinetic simulation. Methods: Using the Minto & Schnider models for remifentanil and propofol respectively, the algorithm was implemented on an iTIVA application (interactive TIVA) for iOS and Android operating systems. The performance of the algorithm was evaluated estimating the infusion regimens for achieving different effect-site concentrations for induction and maintenance in 34 theoretical patients for 240. minutes. Results: The infusion regimens obtained for remifentanil and propofol resulted in less than 5% average systemic deviation versus the target effect-site concentrations during induction and maintenance. Only one induction infusion was required for remifentanil and propofol. Just one infusion rate was required for remifentanil during maintenance, and between 2 to 5 infusion rate changes for propofol to maintain a stable concentration. The iTIVA-based algorithm estimates concentrations similar to the TivaTrainer® software. Conclusions: The performance of the algorithm to achieve effect-site concentrations during induction and maintenance for remifentanil and propofol was excellent, with a low systemic deviation versus the desired target concentrations.

Anesthesia, Computer simulation, Infusion pumps, Pharmacokinetics, Propofol,
Revista Colombiana de Anestesiologia
Erasmus MC: University Medical Center Rotterdam

Ramírez, D.E, & Calvache, J.A. (2016). Design and performance evaluation of the "iTIVA" algorithm for manual infusion of intravenous anesthetics based on effect-site target. Revista Colombiana de Anestesiologia, 44(2), 105–113. doi:10.1016/j.rca.2016.02.002